Lexington biotech plots $86M IPO as key gene therapy trial nears – Boston Business Journal
FierceBiotech |
Lexington biotech plots $86M IPO as key gene therapy trial nears
Boston Business Journal A Lexington biotech developing gene therapy treatments for rare eye diseases has announced plans to raise up to $86 million in an initial public offering. Nightstar Therapeutics, a 23-employee company with a 3,300 square foot office in Lexington and a … Nightstar files for $86M IPO to fund gene therapy trials |
